In line / mixed
Comparable growth improved modestly and pricing strengthened, while broad industrial volumes remained uneven.
[AS-EXP-045]Air Liquide
9M 2025 sales: A small, anticipated sales beat lacked a fresh catalyst against a rich valuation and weak sector tape.
ResultIn line / mixedGuidanceMixed / newly framedEnvironmentmixed
Investment snapshot
What happened and why it mattered
Mixed / newly framed
Management kept the annual profit and margin ambitions intact at the sales update.
[AS-EXP-045]No clear inflection
Management kept the annual profit and margin ambitions intact at the sales update.
[AS-EXP-045]Qualitative
Any initial firmness faded because the result did not change estimates enough to offset sector derating.
[AS-ME-101]Results versus expectations
The print and the three most important read-throughs
Comparable growth improved modestly and pricing strengthened, while broad industrial volumes remained uneven.
- 1
Comparable growth improved modestly and pricing strengthened, while broad industrial volumes remained uneven.
Guidance bridge
GuidanceMixed / newly framedLatest outlook and KPI implications
Management kept the annual profit and margin ambitions intact at the sales update.
| Metric | Prior | Latest | Consensus | Delta | Status | Reason / implication |
|---|---|---|---|---|---|---|
| Start-up / ramp-up sales contribution (FY 2025) | "More than €310m" / €310–340m range (set at FY2024, reiterated H1) | Confirmed €310–340m; "at least €310m" with €233m delivered YTD | NOT AVAILABLE | Confirmed | Updated | Backlog projects flowing to top line as units start up |
| 2022–2026 cumulative OIR margin ambition (excl. energy) | +460 bps over 5 years | +460 bps over 5 years (unchanged) | NOT AVAILABLE | Confirmed | Updated | On-track transformation and efficiency delivery |
| 2025–2026 two-year margin improvement (excl. energy) | +200 bps over two years | +200 bps over two years (unchanged) | NOT AVAILABLE | Confirmed | Updated | Margin "continues to improve, in line with the ambition" |
| Recurring net profit growth (constant FX) | Growth confirmed | Growth confirmed | NOT AVAILABLE | Confirmed | Updated | Operating leverage above sales growth |
| Efficiencies (annual ADVANCE target) | €400m per annum objective | €400m target reaffirmed; €434m already delivered 9M (+22.9%) | NOT AVAILABLE | Ahead of run-rate | Updated | Structural transformation program delivering |
| Investment backlog | €4.6bn at end-June 2025 | New record €4.9bn ("close to €5bn") | NOT AVAILABLE | Increased | Raised | ELYgator and major projects entering backlog |
Management signal — paraphrased
Management kept the annual profit and margin ambitions intact at the sales update.
Implied cadence
Management kept the annual profit and margin ambitions intact at the sales update.
Stock reaction
Why the shares moved
Any initial firmness faded because the result did not change estimates enough to offset sector derating.
- Any initial firmness faded because the result did not change estimates enough to offset sector derating.
Did the reaction persist?
[AS-ME-101]Not independently calculated in the compact record.
Adjusted-close reaction
Independent return windows were not embedded in this compact record. The reaction assessment is qualitative.
Source-reported qualitative reaction; no independent price series embeddedMarket environment delta
EnvironmentmixedWhat management said about the operating backdrop
A small, anticipated sales beat lacked a fresh catalyst against a rich valuation and weak sector tape.
- Customer demandMixed
Customers in "wait and see" mode; macro "much the same as 3Q25" with brighter electronics/healthcare
OutlookEarly 2026 could resemble 2025; recovery not yet visibleKPI implicationCaps near-term volume-driven revenueBroker/management interpretation · Medium confidence · [134] - Volumes / order activityMixed
Large Industries flat as US/Asia ramp-ups offset weak EMEA/Asia base; record backlog to convert into growth
OutlookBacklog ~€4.9bn to flow to top line as units start upKPI implicationStart-up/ramp-up contribution €233m YTD toward €310–340mDisclosed fact · High confidence · [135] - Regional / end-market conditionsMixed
Americas +5% (LI +5.2%), EMEA +0.4%, Asia -0.8%; hydrogen weak in Germany, cogen weak in Benelux
OutlookAmericas leadership to persist; Europe recovery gated on industrial demandKPI implicationDrives geographic mix and group comparableDisclosed fact · High confidence · [138]
- Channel / inventory conditionsImproving
Hardgoods "still down but clearly improving"; gas volumes flat-to-slightly-up, improving sequentially
OutlookContinued sequential hardgoods recovery expectedKPI implicationLeading indicator for IM volume inflectionManagement interpretation · Medium confidence · AS-ME-101 - Supply availabilityWorsening
Helium sales fell sharply in China; liquid CO2 and helium dragged Asia IM (-0.8%)
OutlookHelium headwind expected to persist near-termKPI implicationWeighs on Asia-Pacific comparable growthDisclosed fact · Medium confidence · [136] - Input costs / utilization / capacityImproving
Efficiencies +22.9% YoY, €434m over 9M, already above full-year target; existing capacity a growth driver
OutlookStructural over-delivery; supports margin while funding capexKPI implication+100bps p.a. margin path toward +460bps 2022–26Disclosed fact · High confidence · [137]
- CompetitionStable
NOT DISCUSSED at the sales update as a distinct theme
OutlookRational pricing behaviour expected to persist across majorsKPI implicationUnderpins IM price durabilityBroker/expert evidence · Low confidence · [132] - PricingImproving
IM pricing accelerated to +3.1% in Q3 vs +2.7% in Q2; +4.5% in Americas on cylinder-rental adjustments
OutlookPrice effect expected to keep strengthening (reached +5.2% in Q4 per FY disclosure)KPI implicationDirectly supports OIR margin ex-energyDisclosed fact · High confidence · [133]
Evidence and confidence
Source map
No material gap recorded.
AlphaSense synthesis
Open source ↗Official company source
Open source ↗AlphaSense market-environment synthesis
Open source ↗